A
Angelo Branzi
Researcher at University of Bologna
Publications - 350
Citations - 17546
Angelo Branzi is an academic researcher from University of Bologna. The author has contributed to research in topics: Atrial fibrillation & Heart failure. The author has an hindex of 58, co-authored 350 publications receiving 16425 citations.
Papers
More filters
Journal ArticleDOI
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation.
Mauro Biffi,Matteo Bertini,Matteo Ziacchi,Cristian Martignani,Cinzia Valzania,Igor Diemberger,Angelo Branzi,Giuseppe Boriani +7 more
TL;DR: Left superior vena cava persistence in PM/ICD patients is similar to the general population and the left-sided implant may be skill-demanding during lead placement; however, this task can be accomplished in the majority of cases, with a reliable outcome in the short term and appropriate device performance at follow-up.
Journal ArticleDOI
Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation
Giuseppe Boriani,Mauro Biffi,Alessandro Capucci,Gabriele Bronzetti,Gregory M. Ayers,Romano Zannoli,Angelo Branzi,Bruno Magnani +7 more
TL;DR: Intravenous flecainide reduces atrial defibrillation threshold in patients treated with low-energy internal atrial cardioversion and may increase the procedure success rate in patients with chronic persistent atrial fibrillation.
Journal ArticleDOI
Seven-year follow-up after dobutamine stress echocardiography: Impact of gender on prognosis
Elena Biagini,Abdou Elhendy,Jeroen J. Bax,Vittoria Rizzello,Arend F.L. Schinkel,Ron T. van Domburg,Miklos D. Kertai,Boudewijn J. Krenning,Manolis Bountioukos,Claudio Rapezzi,Angelo Branzi,Maarten L. Simoons,Don Poldermans +12 more
TL;DR: In patients with normal DSE, gender is independently associated with cardiac events, and the outcome of patients with abnormal DSE is not related to gender, after adjusting for stress echocardiographic abnormalities.
Journal ArticleDOI
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention.
Paolo Ortolani,Antonio Marzocchi,Cinzia Marrozzini,Tullio Palmerini,Francesco Saia,Nevio Taglieri,Federica Baldazzi,Simona Silenzi,Maria Letizia Bacchi-Reggiani,Paolo Guastaroba,Roberto Grilli,Angelo Branzi +11 more
TL;DR: E evaluation of hs-C-reactive protein on admission in STEMI patients undergoing primary PCI allows reliable risk stratification of these patients, and appears to be an independent predictor of long-term mortality.
Journal ArticleDOI
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response
Giuseppe Boriani,François Regoli,Davide Saporito,Cristian Martignani,Tiziano Toselli,Mauro Biffi,Gloria Francolini,Igor Diemberger,Letizia Bacchi,Claudio Rapezzi,Roberto Ferrari,Angelo Branzi +11 more
TL;DR: 3 months of CRT significantly reduce natriuretic peptides concentrations, while values of other neurohormones and inflammatory cytokines are relatively unvaried, and a baseline ANP concentration might be a clinically useful predictor of medium-term response to CRT.